Craft
  • Home
  •  / Monte Rosa Therapeutics
Monte Rosa Therapeutics

Monte Rosa Therapeutics

Market Capitalization

$359 M

2022-09-20

Monte Rosa Therapeutics Summary

Company summary

Overview
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. Its technology treats cancer cells through small-molecule drugs that reprogram ubiquitin ligases to eliminate disease drivers.
Type
Public
Founded
2018
HQ
Boston, MA, US | view all locations
Website
https://www.monterosatx.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Markus Warmuth

    Markus Warmuth, Chief Executive Officer

  • Ajim Tamboli

    Ajim Tamboli, Chief Financial Officer

  • Sharon Townson

    Sharon Townson, Chief Technology Officer

  • Owen Wallace

    Owen Wallace, Chief Scientific Officer

LocationsView all

6 locations detected

  • Boston, MA HQ

    United States

    645 Summer St

  • Boston, MA

    United States

    40 Guest St

  • Cambridge, MA

    United States

    One Broadway, 1 Broadway 14th floor

  • Basel, BS

    Switzerland

    Aeschenvorstadt 36

  • Basel, BS

    Switzerland

    Hochbergerstrasse 60C

  • Basel, BS

    Switzerland

    Klybeckstrasse 191/136

Monte Rosa Therapeutics Financials

Summary financials

Footer menu